KalVista Pharmaceuticals (KALV) Reports Q1 Loss of $0.47/Share

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q1 EPS of ($0.47), versus ($0.51) reported last year. Revenue for the quarter came in at $3.7 million, versus $10 thousand reported last year.

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• AeroVironment (AVAV) Tops Q4 EPS by 36c
• Doximity downgraded by BofA on AI investment concerns, margin pressure